BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SUFU, RP11-47A8_1, 51684, ENSG00000121410, PRO1280, SUFUXL, Q9UMX1, SUFUH AND Prognosis
3673 results:

  • 1. [Identification of key genes in Wilms tumor based on high-throughput RNA sequencing and their impacts on prognosis and immune responses].
    Gao Z; Lin J; Hong P; Hu Z; Dong J; Shi Q; Tian X; Liu F; Wei G
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):727-738. PubMed ID: 38708507
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification of prognostic stemness-related genes in kidney renal papillary cell carcinoma.
    Liu Y; Yao Y; Zhang Y; Xu C; Yang T; Qu M; Lu B; Song X; Pan X; Zhou W; Cui X
    BMC Med Genomics; 2024 May; 17(1):121. PubMed ID: 38702698
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Establishment and validation of a nomogram for predicting overall survival of upper-tract urothelial carcinoma with bone metastasis: a population-based study.
    Hu J; Gu H; Zhang D; Wen M; Yan Z; Song B; Xie C
    BMC Urol; 2024 Apr; 24(1):100. PubMed ID: 38689213
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study.
    Ni J; Yao X; Song W; Zhang H; Zhang H; Wang Y; Zhang Y; Wang G; Wang K; Mao W; Peng B
    Cancer Med; 2024 May; 13(9):e7214. PubMed ID: 38686610
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel pyroptosis-related gene signature exhibits distinct immune cells infiltration landscape in Wilms' tumor.
    Guo Y; Lu W; Zhang Z; Liu H; Zhang A; Zhang T; Wu Y; Li X; Yang S; Cui Q; Li Z
    BMC Pediatr; 2024 Apr; 24(1):279. PubMed ID: 38678251
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The survival benefit of metastasectomy for metastatic non-clear cell renal cell carcinoma: a retrospective cohort study.
    Dai J; He B; Zhang Y; Zhang H; Hu X; Xu L; Ni Y; Zhang X; Sun G; Zeng H; Shen P; Liu Z
    World J Urol; 2024 Apr; 42(1):259. PubMed ID: 38662226
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
    Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
    Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association between PD-L1 Expression and the prognosis and Clinicopathologic Features of Non-Clear Cell Renal Cell Carcinoma.
    Chrabańska M; Szweda-Gandor N; Rynkiewicz M; Hraboš D; Drozdzowska B
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612724
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Machine learning-based integration develops a stress response stated T cell (Tstr)-related score for predicting outcomes in clear cell renal cell carcinoma.
    Yang S; Han Z; Tan Z; Wu Z; Ye J; Cai S; Feng Y; He H; Wen B; Zhu X; Ye Y; Huang H; Wang S; Zhong W; Deng Y
    Int Immunopharmacol; 2024 May; 132():112017. PubMed ID: 38599101
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. PMab-314: An Anti-Giant Panda Podoplanin Monoclonal Antibody.
    Ouchida T; Li G; Suzuki H; Yanaka M; Nakamura T; Handa S; Tanaka T; Kaneko MK; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2024 Apr; 43(2):53-58. PubMed ID: 38593441
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Vaporization phosphorization-mediated synthesis of phosphorus-doped TiO
    Song Z; Guan C; Li T; Li C; Zhang N; Liu K; Yang C; Zhu Y; Xu Y
    J Mater Chem B; 2024 Apr; 12(16):4039-4052. PubMed ID: 38591157
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. GHITM regulates malignant phenotype and sensitivity to PD-1 blockade of renal cancer cells via Notch signalling.
    Huang S; Liu J; Hu J; Hou Y; Hu M; Zhang B; Luo H; Fu S; Chen Y; Liu X; Chen Z; Wang L
    J Cell Mol Med; 2024 Apr; 28(8):e18290. PubMed ID: 38588015
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Impact of perioperative blood transfusion on prognosis after nephrectomy in patients with renal cell carcinoma: A meta-analysis and systematic review.
    Xu J; Bai J; Pan H; Zhou Z
    Medicine (Baltimore); 2024 Apr; 103(14):e37646. PubMed ID: 38579099
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. External validation of a four-tiered grading system for chromophobe renal cell carcinoma.
    Liu S; Hou M; Yao Y; Mei J; Sun L; Zhang G
    Clin Exp Med; 2024 Mar; 24(1):61. PubMed ID: 38554222
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Recurrence of locally invasive retroperitoneal dedifferentiated liposarcoma shortly after surgery: A case report and literature review.
    Hu X; Han B; Yang Q; Li Q; Xiao D; Xu X
    Medicine (Baltimore); 2024 Mar; 103(13):e37604. PubMed ID: 38552050
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effect of galectin-1 on prognosis and responsiveness of immune checkpoint plus tyrosine kinase inhibition in renal cell carcinoma.
    Wang J; Zhang S; Wang Y; Zhu Y; Xu X; Guo J
    Cancer Med; 2024 Apr; 13(7):e7113. PubMed ID: 38545824
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nomogram for personalized prognostic assessment of children with favorable histology Wilms tumor: A retrospective analysis.
    Wang Z; Li J; Liu P; Xie X; Song H; Zhang W
    Urol Oncol; 2024 Jun; 42(6):178.e1-178.e10. PubMed ID: 38522976
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bioinformatics analysis highlights CCNB1 as a potential prognostic biomarker and an anti-kidney renal papillary cell carcinoma drug target.
    Gong X; Gong Y; Wu G; Ke H
    Medicine (Baltimore); 2024 Mar; 103(12):e37609. PubMed ID: 38518000
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Identification and validation of a novel signature based on macrophage marker genes for predicting prognosis and drug response in kidney renal clear cell carcinoma by integrated analysis of single cell and bulk RNA sequencing.
    Chen X; Zhang Z; Qin Z; Zhu X; Wang K; Kang L; Li C; Wang H
    Aging (Albany NY); 2024 Mar; 16(6):5676-5702. PubMed ID: 38517387
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 184.